Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-α-Synuclein Monoclonal Antibody, in Patients With Parkinson's Disease: A Randomized Clinical Trial. Here, SNCA is linked to Parkinson disease.